---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-026428"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2026-08-07T11:00:32+00:00"
generated_at: "2026-08-07T11:05:26.305922+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals FDA ANDA review: no drug deficiencies; packaging issue to resolve

## Summary
- FDA first-round ANDA review for preservative-free ketamine found no major drug-component deficiencies (July 30, 2026).
- One major deficiency: twist-off cap on luer lock vial; FDA wants confirmation no patient-safety risk from tip deformation.
- Company cited 11.9M doses shipped across 3 approved ANDA products with same vial; 3,500 vials from 7 batches tested with no defects.
- Aug 6 clarification meeting with FDA Office of Generic Drugs; FDA requested manufacturer certifications on same lines/machinery, committed to shortest review cycle.
- FDA recognizes ketamine as strategic drug on shortage list; management optimistic for first commercial sales in 2026.

## SEC filing metadata
- accession: 0001437749-26-026428
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2026-08-07T11:00:32+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774926026428/0001437749-26-026428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774926026428/nrxp20260806_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-026428
- JSON: https://secwatch.observer/filing/0001437749-26-026428.json
- Plain text: https://secwatch.observer/filing/0001437749-26-026428.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.